为未来需求而设计的欧洲扩张

为了为400名员工创造空间，Integra Biosciences已开始扩大其在瑞士Zizers的总部。战略举动耗资超过1亿瑞士法郎，将看到Integra校园的发展，30,000 m²创建和创新的网站，到2028年提供250个新工作。

这家实验室技术公司的计划包括具有注射模制系统的新生产设施，使用高度的自动化，从而使其获得专利的Griptip移液器提示和其他消耗品（目前在新罕布什尔州哈德逊市生产）首次在欧洲生产。

该校园的创意村旨在培养创新，开放式工作区域和内部实验室，并容纳公司的工程，营销，IT和行政职能。新设施还将为Integra的可持续发展计划做出贡献，旨在通过屋顶安装的光伏系统，热泵和电动汽车充电站大大降低公司的碳足迹。

this expansion has been designed to meet a growing global demand for the company’s robots, laboratory products and pipettes, which have seen an average annual sales growth of 23% over the last 10 years, as well as an unprecedented 73% rise in 2020. CEO Urs Hartmann said: “We are seeing stronger and faster growth than ever before, so we want to further increase capacity in all areas of the business. The construction of the Integra Campus will enable us to develop the Zizers site for the long term, as well as move to round-the-clock consumables production to ensure we continue to meet our customers’ needs.”

更多信息在线的